Skip to main content
Funding round brings in $14.8M for ivWatch

A round of financing has pulled in $14.8 million for ivWatch, which makes the FDA-cleared ivWatch Model 400 device to provide continuous monitoring of peripheral IV for the detection of infiltration and extravasation events. The company intends to use the money for strategic partner activities and direct go-to-market efforts.

Full Story: